"ITGAM" Related Products

Expand
Expand

Recombinant Human CD-11b

Cat. No.: CDA082P
Product Overview: Recombinant Human CD-11b protein 936-1154 a.a. expressed in E.coli,52 kDa.
Description: Leukocyte associated protein consists of two polypeptide chains with molecular weights 95 and 170kDa. The moleculae functions as a cell surface receptor for the C3bi complement fragment. It belongs to family of heterodimeric proteins (designated CD11) which share a common beta chain CD18 of 95kDa. The alpha chain component of the leukocyte associated antigen is expressed on granulocytes, monocytes and macrophages.
Synonyms: ITGAM; CD11B; CR3A; MAC-1; MAC1A; MGC117044; MO1A; CD11b 1; SLEB6; CD11 antigen-like family member B; CD11b antigen; CR-3 alpha chain; Cell surface glycoprotein MAC-1 subunit alpha; Leukocyte adhesion receptor MO1; Neutrophil adherence receptor; antigen CD11b (p170); complement component receptor 3, alpha integrin alpha M; integrin, alpha M (complement component 3 receptor 3 subunit); integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide); macrophage antigen alpha polypeptide; neutrophil adherence receptor alpha-M subunit 2; integrin alpha M; neutrophil adherence receptor alpha-M subunit.
Source: E.coli
Presentation: 5ug/50ul Recombinant Human CD-11b protein at 100µg/1ml in 50mM Tris-Acetate, pH7.5, 1mM EDTA and 20% Glycerol.
Applications: •ELISA•Inhibition Assays •Western Blotting
Characterization: On SDS-PAGE commassie blue stained gel, the purified recombinant protein shows a band at 52 kDa.
Activity: Not known.
Storage: Store vial at -20°Cto -80°C. When stored at the recommended temperature, this protein is stable for 12 months.

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.